Skip to main content
Log in

Long-term effects of one-anastomosis gastric bypass on liver histopathology in NAFLD cases: a prospective study

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Purpose

Weight reduction can effectively improve nonalcoholic fatty liver disease (NAFLD), which is a constant companion of severe obesity. This study aimed to determine the effect of one-anastomosis gastric bypass (OAGB) on pathological liver changes in severely obese cases with NAFLD.

Methods

The present prospective research comprised 67 subjects with morbid obesity scheduled for OAGB during the period from February 2015 to August 2018. Clinical, biological, and histologic data were evaluated pre and 15 months postoperatively.

Results

Fifteen months after surgery, a considerable reduction was noted in the grades of fat deposition, liver cell ballooning, and lobular inflammatory changes, in addition to the total NAS score. Fifteen months after surgery, nonalcoholic steatohepatitis (NASH) disappeared in 42% of the patients. A significant regression of fibrosis stage occurred after surgery in 79.1% of patients (p < 0.001). After surgery, patients had substantial reductions in aspartate aminotransferase, alanine aminotransferase, γ-glutamyltransferase, HbA1c, total cholesterol, and Low-density lipoprotein (p < 0.001, for all comparisons). Diabetes mellitus, hypertension, and dyslipidemia resolved in 54%, 59%, and 69% of the patients, respectively.

Conclusion

OAGB resolved NASH from nearly 42% of patients and reduced the histological features of NAFLD 15 months after surgery. Bariatric procedures might be adopted as a therapeutic modality in severely obese cases with NAFLD after the failure of lifestyle modifications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Engin A (2017) The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol 960:1–17

    Article  CAS  Google Scholar 

  2. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C et al (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Lond Engl 384:766–781

    Article  Google Scholar 

  3. Fabbrini E, Magkos F (2015) Hepatic steatosis as a marker of metabolic dysfunction. Nutrients 7:4995–5019

    Article  CAS  Google Scholar 

  4. Gastaldelli A (2010) Fatty liver disease: the hepatic manifestation of metabolic syndrome. Hypertens Res 33:546–547

    Article  Google Scholar 

  5. Clark JM (2006) The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 40(Suppl 1):S5–10

    PubMed  Google Scholar 

  6. Blackburn GL, Mun EC (2004) Effects of weight loss surgeries on liver disease. Semin Liver Dis 24:371–379

    Article  Google Scholar 

  7. Lindenmeyer CC, McCullough AJ (2018) The natural history of nonalcoholic fatty liver disease—an evolving view. Clin Liver Dis 22:11–21

    Article  Google Scholar 

  8. Polyzos SA, Kountouras J, Mantzoros CS (2019) Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metab Clin Exp 92:82–97

    Article  CAS  Google Scholar 

  9. Leung JC-F, Loong TC-W, Wei JL, Wong GL-H, Chan AW-H, Choi PC-L et al (2017) Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients. Hepatol Baltim Md 65:54–64

    Article  CAS  Google Scholar 

  10. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M et al (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844–1850

    Article  CAS  Google Scholar 

  11. Fan J, Zhou Q, Wo Q (2010) Effect of body weight mass and its change on the incidence of nonalcoholic fatty liver disease [Zhonghua Gan Zang Bing Za Zhi Zhonghua Ganzangbing Zazhi]. Chin J Hepatol 18:676–679

    CAS  Google Scholar 

  12. Zelber-Sagi S, Lotan R, Shlomai A, Webb M, Harrari G, Buch A et al (2012) Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol 56:1145–1151

    Article  Google Scholar 

  13. Musso G, Cassader M, Rosina F, Gambino R (2012) Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 55:885–904

    Article  CAS  Google Scholar 

  14. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L et al (2015) Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149(367–378):e5 (quiz e14–15)

    Google Scholar 

  15. Zelber-Sagi S, Kessler A, Brazowsky E, Webb M, Lurie Y, Santo M et al (2006) A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 4:639–644

    CAS  Google Scholar 

  16. Laursen TL, Hagemann CA, Wei C, Kazankov K, Thomsen KL, Knop FK et al (2019) Bariatric surgery in patients with nonalcoholic fatty liver disease—from pathophysiology to clinical effects. World J Hepatol 11:138–149

    Article  Google Scholar 

  17. Colquitt JL, Pickett K, Loveman E, Frampton GK (2014) Surgery for weight loss in adults. Cochrane Database Syst Rev 8:CD003641

    Google Scholar 

  18. Tannapfel A, Denk H, Dienes HP, Langner C, Schirmacher P, Trauner M et al (2010) Histopathological diagnosis of nonalcoholic and alcoholic fatty liver disease: grade 2 consensus-based guidelines. Pathology 31:225–237

    CAS  Google Scholar 

  19. Sjöström L, Lindroos A-K, Peltonen M, Torgerson J, Bouchard C, Carlsson B et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693

    Article  Google Scholar 

  20. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G et al (2015) Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet Lond Engl 386:964–973

    Article  Google Scholar 

  21. Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E et al (2013) Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988–1994. Am J Epidemiol 178:38–45

    Article  Google Scholar 

  22. Romero-Gómez M, Zelber-Sagi S, Trenell M (2017) Treatment of NAFLD with diet, physical activity and exercise. J Hepatol 67:829–846

    Article  Google Scholar 

  23. Koutoukidis DA, Astbury NM, Tudor KE, Morris E, Henry JA, Noreik M et al (2019) Association of weight loss interventions with changes in biomarkers of nonalcoholic fatty liver disease: a systematic review and meta-analysis. JAMA Intern Med 179(9):1262–1271

    Article  Google Scholar 

  24. Shalhub S, Parsee A, Gallagher SF, Haines KL, Willkomm C, Brantley SG et al (2004) The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Obes Surg 14:54–59

    Article  Google Scholar 

  25. Machado M, Marques-Vidal P, Cortez-Pinto H (2006) Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol 45:600–606

    Article  Google Scholar 

  26. Taitano AA, Markow M, Finan JE, Wheeler DE, Gonzalvo JP, Murr MM (2015) Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg Off J Soc Surg Aliment Tract. 19:429–436 (discussion 436–437)

    Article  Google Scholar 

  27. Froylich D, Corcelles R, Daigle C, Boules M, Brethauer S, Schauer P (2016) Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study. Surg Obes Relat Dis Off J Am Soc Bariatr Surg 12:127–131

    Article  Google Scholar 

  28. Caiazzo R, Lassailly G, Leteurtre E, Baud G, Verkindt H, Raverdy V et al (2014) Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg. 260:893–898 (discussion 898–899)

    Article  Google Scholar 

  29. von Schönfels W, Beckmann JH, Ahrens M, Hendricks A, Röcken C, Szymczak S et al (2018) Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score). Surg Obes Relat Dis Off J Am Soc Bariatr Surg 14:1607–1616

    Article  Google Scholar 

  30. Algooneh A, Almazeedi S, Al-Sabah S, Ahmed M, Othman F (2016) Nonalcoholic fatty liver disease resolution following sleeve gastrectomy. Surg Endosc 30:1983–1987

    Article  Google Scholar 

  31. Nickel F, Tapking C, Benner L, Sollors J, Billeter AT, Kenngott HG et al (2018) Bariatric surgery as an efficient treatment for nonalcoholic fatty liver disease in a prospective study with 1-year follow-up: BariScan study. Obes Surg 28:1342–1350

    Article  Google Scholar 

  32. Tai C-M, Huang C-K, Hwang J-C, Chiang H, Chang C-Y, Lee C-T et al (2012) Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients. Obes Surg 22:1016–1021

    Article  Google Scholar 

  33. Fakhry TK, Mhaskar R, Schwitalla T, Muradova E, Gonzalvo JP, Murr MM (2019) Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis. Surg Obes Relat Dis Off J Am Soc Bariatr Surg 15:502–511

    Article  Google Scholar 

  34. Motamedi MAK, Rakhshani R, Khalaj A, Barzin M (2017) Biopsy-proven progressive fatty liver disease nine months post mini-gastric bypass surgery: a case study. Int J Surg Case Rep 39:168–171

    Article  Google Scholar 

  35. Brunt EM, Wong VW-S, Nobili V, Day CP, Sookoian S, Maher JJ et al (2015) Nonalcoholic fatty liver disease. Nat Rev Dis Primer 1:15080

    Article  Google Scholar 

  36. Cusi K (2009) Role of insulin resistance and lipotoxicity in nonalcoholic steatohepatitis. Clin Liver Dis 13:545–563

    Article  Google Scholar 

  37. Lewis GF, Carpentier A, Adeli K, Giacca A (2002) Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23:201–229

    Article  CAS  Google Scholar 

  38. Wadden TA, Volger S, Sarwer DB, Vetter ML, Tsai AG, Berkowitz RI et al (2011) A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med 365:1969–1979

    Article  CAS  Google Scholar 

Download references

Funding

This study was supported by the authors. No other fund was received.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmed Abdallah Salman.

Ethics declarations

Disclosures

Drs. Mohamed Abdalla Salman, Ahmed Abdallah Salman, Haitham SE Omar, Ahmed Abdelsalam, Mohamed Saber Mostafa, Mohamed Tourky, Ahmed Abd El Aal Sultan, Mohammed Hassan Elshafey, Walid Rafat Abdelaty, Abdoh Salem, Osama Osman Khaliel, Hossam E Elshafey, Mohamed Atallah, Hossam El-Din Shaaban, Mohamed Yousef, and Mohammed A Nafea have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salman, M.A., Salman, A.A., Omar, H.S.E. et al. Long-term effects of one-anastomosis gastric bypass on liver histopathology in NAFLD cases: a prospective study. Surg Endosc 35, 1889–1894 (2021). https://doi.org/10.1007/s00464-020-07725-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-020-07725-y

Keywords

Navigation